|
EIF5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.49189999999011E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.44869999960807E-07 |
| Normal-vs-Stage2 |
5.398600E-03 |
| Normal-vs-Stage3 |
3.083200E-03 |
| Normal-vs-Stage4 |
2.257900E-02 |
| Stage1-vs-Stage2 |
9.140600E-01 |
| Stage1-vs-Stage3 |
1.593360E-01 |
| Stage1-vs-Stage4 |
2.798600E-03 |
| Stage2-vs-Stage3 |
4.813200E-01 |
| Stage2-vs-Stage4 |
1.544550E-01 |
| Stage3-vs-Stage4 |
2.473200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.212700E-04 |
| Normal-vs-AfricanAmerican |
1.19860000036276E-07 |
| Normal-vs-Asian |
4.441300E-03 |
| Caucasian-vs-AfricanAmerican |
1.975180E-03 |
| Caucasian-vs-Asian |
1.633380E-01 |
| AfricanAmerican-vs-Asian |
6.837600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.45180000000489E-05 |
| Normal-vs-Female |
1.642520E-04 |
| Male-vs-Female |
4.226000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.680400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.985800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.15939999999426E-05 |
| Normal-vs-Age(81-100Yrs) |
4.195500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.019200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.900000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.682200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.184600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.974000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.834000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.337780E-02 |
| Normal-vs-Grade 2 |
1.044200E-03 |
| Normal-vs-Grade 3 |
5.72360000505867E-08 |
| Normal-vs-Grade 4 |
2.739400E-01 |
| Grade 1-vs-Grade 2 |
3.443200E-01 |
| Grade 1-vs-Grade 3 |
9.755200E-01 |
| Grade 1-vs-Grade 4 |
6.383700E-02 |
| Grade 2-vs-Grade 3 |
6.323800E-02 |
| Grade 2-vs-Grade 4 |
2.739800E-02 |
| Grade 3-vs-Grade 4 |
4.17219999999663E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.596120E-04 |
| Normal-vs-ccB subtype |
2.837700E-03 |
| ccA subtype-vs-ccB subtype |
5.281200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70200000000542E-05 |
| Normal-vs-N1 |
5.008600E-01 |
| N0-vs-N1 |
1.392210E-01 |
|
|
